Skip to content
value.today
Total raised
$80 M
5 rounds on record
Latest round
$13 M
Jul 2023
First round on record
Jul 2017
Today
Private
No later event on record

Funding rounds

5 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of RareCyte, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Jul 2023$13 MNo. 5$10 to $50 million

RareCyte, Inc.: Raise no. 5, Jul 2023

Investors in this round

19 investors had bought by the notice of Jul 25, 2023: 19 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$13 M of $36 M offered; $23 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Joseph J. Victor Jr. · Executive Officer, Director
  • Stephen J. Reichenbach · Executive Officer
  • Andrew J. Schwab · Director
  • Daniel J. Marshak · Director
  • David J. Kabakoff · Director
  • Jan J. Garfinkle · Director
  • Robert J. Weisskoff · Director
  • Ronald J. Seubert · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Joseph J. Victor, Jr., Chief Executive Officer. Source: SEC Form D, newest notice filed Jul 25, 2023. Read the notice at the SEC.

equity, optionsSEC
Aug 2021$24 MNo. 4$10 to $50 million

RareCyte, Inc.: Raise no. 4, Aug 2021

Investors in this round

27 investors had bought by the notice of Sep 10, 2021: 27 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$24 M of $24 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Joseph J. Victor Jr. · Executive Officer, Director
  • Andrew J. Schwab · Director
  • Daniel J. Marshak · Director
  • David J. Kabakoff · Director
  • Jan J. Garfinkle · Director
  • Robert J. Weisskoff · Director
  • Ronald J. Seubert · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Joseph J. Victor, Jr., Chief Executive Officer. Source: SEC Form D, newest notice filed Sep 10, 2021. Read the notice at the SEC.

equitySEC
Dec 2019$22 MNo. 3$10 to $50 million

RareCyte, Inc.: Raise no. 3, Dec 2019

Investors in this round

0 investors had bought by the notice of Dec 26, 2019: 0 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$22 M of $22 M offered
Smallest investment taken
no minimum stated
What was sold
equity, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Jim J. Cooper · Executive Officer
  • Joseph J. Victor Jr. · Executive Officer, Director
  • Andrew J. Schwab · Director
  • David J. Kabakoff · Director
  • Frank J. Witney · Director
  • Ronald J. Seubert · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Joseph J. Victor, Jr., Chief Executive Officer. Source: SEC Form D, newest notice filed Dec 26, 2019. Read the notice at the SEC.

equitySEC
May 2018$5 MNo. 2$2 to $10 million

RareCyte, Inc.: Raise no. 2, May 2018

Investors in this round

1 investor had bought by the notice of May 24, 2018: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$5 M of $5 M offered
Smallest investment taken
no minimum stated
What was sold
equity, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Eric Kaldjian · Executive Officer
  • Joseph Victor · Executive Officer, Director
  • Ronald Seubert · Executive Officer, Director, Promoter
  • Brian Daniels · Director
  • Frank Witney · Director
  • Robert Shepler · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Joseph Victor, Chief Executive Officer. Source: SEC Form D, newest notice filed May 24, 2018. Read the notice at the SEC.

equitySEC
Jul 2017$15 MNo. 1$10 to $50 million

RareCyte, Inc.: Raise no. 1, Jul 2017

Investors in this round

9 investors had bought by the notice of Aug 10, 2017: 9 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$15 M of $16 M offered; $1 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Eric Kaldjian · Executive Officer
  • Evan Castiglia · Executive Officer
  • Joseph Victor · Executive Officer, Director
  • Ronald Seubert · Executive Officer, Director, Promoter
  • Brian Daniels · Director
  • Frank Witney · Director
  • Robert Shepler · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Joseph Victor, Chief Executive Officer. Source: SEC Form D, newest notice filed Aug 10, 2017. Read the notice at the SEC.

equity, optionsSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • RareCyte, Inc. chose not to state its revenue in its newest notice of a funding round (Jul 2023).

    SEC Form D · Jul 2023

  • The industry group it chose in its notices: Other.

    SEC Form D · Jul 2023

That is all the official record says: RareCyte, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of RareCyte, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 5 rounds above had up to 27 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by RareCyte, Inc.
NameRoleNamed in
Joseph J. Victor Jr.Executive officerJul 2023
Stephen J. ReichenbachExecutive officerJul 2023
Jim J. CooperExecutive officerDec 2019
Eric KaldjianExecutive officerMay 2018
Joseph VictorExecutive officerMay 2018
Ronald SeubertExecutive officerMay 2018
Evan CastigliaExecutive officerAug 2017
Andrew J. SchwabDirectorJul 2023
Daniel J. MarshakDirectorJul 2023
David J. KabakoffDirectorJul 2023
Jan J. GarfinkleDirectorJul 2023
Joseph J. Victor Jr.DirectorJul 2023
Robert J. WeisskoffDirectorJul 2023
Ronald J. SeubertDirectorJul 2023
Frank J. WitneyDirectorDec 2019
Brian DanielsDirectorMay 2018
Frank WitneyDirectorMay 2018
Joseph VictorDirectorMay 2018
Robert SheplerDirectorMay 2018
Ronald SeubertDirectorMay 2018
Ronald SeubertPromoterMay 2018